Farmworker Mobility and COVID-19 Vaccination Strategies: Yuma County, Arizona, 2021
Am J Trop Med Hyg. 2024 Apr 23:tpmd220789. doi: 10.4269/ajtmh.22-0789. Online ahead of print.ABSTRACTFarmworkers, a group of essential workers, experience a disproportionately high burden of COVID-19 due to their living and working conditions. This project characterized farmworker mobility in and around Yuma County, Arizona, to identify opportunities to improve farmworker access to COVID-19 vaccination. We collected qualitative and geospatial data through a series of in-person and virtual focus group discussions, key informant interviews, and intercept interviews with participatory mapping. Participants included farmworker...
Source: Am J Trop Med Hyg - April 23, 2024 Category: Infectious Diseases Authors: Katherine A Franc Alba E Phippard Priscila Ruedas Sarah J Pinto Kanan Mehta Sonia Montiel Sonia Contreras Hannah Katz Elvira McIntyre Benito Lopez Michelle Kreutzberg-Martinez Daisy Steiner Diana Gomez Rebecca Merrill Source Type: research
Vaksinen øling under koronapandemien blant unge med etnisk minoritetsbakgrunn i Oslo øst – en kvalitativ studie
Tidsskr Nor Laegeforen. 2024 Apr 8;144(5). doi: 10.4045/tidsskr.23.0690. Print 2024 Apr 23.ABSTRACTBACKGROUND: Few studies have been conducted on young people's attitudes to the COVID-19 vaccine during the pandemic. We wished to examine how young people with an ethnic minority background decided whether to have the COVID-19 vaccine, based on the concept of vaccine hesitancy. Vaccine hesitancy involves uncertainty with regard to vaccination, irrespective of the decision taken.MATERIAL AND METHOD: Fourteen qualitative in-depth interviews with young people aged 16-25 years with an ethnic minority background and from the east ...
Source: Tidsskrift for den Norske Laegeforening - April 23, 2024 Category: General Medicine Authors: Madhumitha Sentamilvannan Abir Al-Dekany Helena Niemi Eide Anne Kveim Lie Source Type: research
Survival and safety analysis of COVID ‐19 vaccine in Chinese patients with non‐small cell lung cancer
ConclusionsCOVID-19 vaccination is safe for Chinese NSCLC patients actively receiving different antitumor treatments without increasing the incidence of adverse reactions, and vaccination does not affect cancer patient survival. (Source: Cancer Medicine)
Source: Cancer Medicine - April 23, 2024 Category: Cancer & Oncology Authors: Wei Xu,
Jing Zhao,
Fang Luan,
Zhizhao Zhang,
Lei Liu,
Hui Zhao,
Bin Feng,
Guobin Fu Tags: RESEARCH ARTICLE Source Type: research
Current Progress, Challenges and Prospects in the Development of COVID-19 Vaccines
AbstractThe COVID-19 pandemic has resulted in over 772 million confirmed cases, including nearly 7 million deaths, according to the World Health Organization (WHO). Leveraging rapid development, accelerated vaccine approval processes, and large-scale production of various COVID-19 vaccines using different technical platforms, the WHO declared an end to the global health emergency of COVID-19 on May 5, 2023. Current COVID-19 vaccines encompass inactivated, live attenuated, viral vector, protein subunit, nucleic acid (DNA and RNA), and virus-like particle (VLP) vaccines. However, the efficacy of these vaccines is diminishing...
Source: Drugs - April 23, 2024 Category: Drugs & Pharmacology Source Type: research
The characteristics of white dot syndromes following COVID-19 Vaccines: a systematic review
ConclusionWhite dot syndromes are very rare entities. Our findings highlight a possible association between COVID-19 vaccines and the occurrence of white dot syndromes. However, larger studies with good quality should be implemented to confirm these findings. (Source: International Ophthalmology)
Source: International Ophthalmology - April 23, 2024 Category: Opthalmology Source Type: research
Anti-spike antibody level is associated with the risk of clinical progression among subjects hospitalized with COVID-19 pneumonia: results from a retrospective cohort study
ConclusionThis study suggests that levels of anti-S antibodies can predict critical or fatal outcomes in COVID-19 pneumonia patients, regardless of vaccination. Whether anti-S Ab could guide risk assessment and vaccination boosting merits further evaluation. (Source: Infection)
Source: Infection - April 23, 2024 Category: Infectious Diseases Source Type: research
Veno-venous extracorporeal membrane oxygenation for covid-19 in postpartum patients: 1-year outcome
During the pandemic, a significant number of patients with severe COVID-19 pneumonia required intensive care. Among these, peripartum women were particularly susceptible to severe respiratory symptoms. This complex pathophysiology involves mechanical and hormonal pathways, including the presence of lung restriction 1, modulation of the immune system by pregnancy 2, and increased oxygen demand 3. Additionally, a high level of vaccine hesitancy in this population meant that most pregnant women were not vaccinated during the COVID-19 pandemic 4. (Source: Journal of Cardiothoracic and Vascular Anesthesia)
Source: Journal of Cardiothoracic and Vascular Anesthesia - April 23, 2024 Category: Anesthesiology Authors: Alexandra P álfi, Éva Zöllei, Zoltán Varga, László B. Tomozi, Domonkos Schulcz, Gábor Bari, Ferenc Peták, Fruzsina Kun-Szabó, Kristóf Baráth, László Rudas, Ádám L. Balogh, Barna Babik Tags: Case Report Source Type: research
Does the SARS-CoV-2 mRNA vaccine and its serum IgG levels affect fertility treatments and obstetric outcomes? An observational cohort study
ConclusionWe cautiously state that the COVID-19 mRNA vaccine does not affect fertility outcomes, including fertilization, pregnancy and delivery rates, obstetric outcomes, and semen parameters, regardless of measured IgG levels. (Source: Clinical and Experimental Medicine)
Source: Clinical and Experimental Medicine - April 23, 2024 Category: Research Source Type: research
Understanding the factors associated with COVID-19 vaccine hesitancy in Venezuela
Despite nearly a quarter of Venezuelans remaining unvaccinated against coronavirus disease 2019 (COVID-19), the factors contributing to vaccine hesitancy in the country have not been thoroughly investigated. (Source: BMC Public Health)
Source: BMC Public Health - April 23, 2024 Category: Consumer Health News Authors: Fabi án R. Chacón-Labrador, María G. Passantino, Augusto Moncada-Ortega, Atahualpa A. Ávila, Andrea A. Moreno, Nicolle A. Kuffaty-Akkou, Luisana M. Pedroza, Natasha A. Camejo-Ávila, Daniela L. Mendoza-Millán, Carlis M. Rodriguez-Saavedra, María V. Tags: Research Source Type: research
Anti-spike antibody level is associated with the risk of clinical progression among subjects hospitalized with COVID-19 pneumonia: results from a retrospective cohort study
ConclusionThis study suggests that levels of anti-S antibodies can predict critical or fatal outcomes in COVID-19 pneumonia patients, regardless of vaccination. Whether anti-S Ab could guide risk assessment and vaccination boosting merits further evaluation. (Source: Infection)
Source: Infection - April 23, 2024 Category: Infectious Diseases Source Type: research
Does the SARS-CoV-2 mRNA vaccine and its serum IgG levels affect fertility treatments and obstetric outcomes? An observational cohort study
ConclusionWe cautiously state that the COVID-19 mRNA vaccine does not affect fertility outcomes, including fertilization, pregnancy and delivery rates, obstetric outcomes, and semen parameters, regardless of measured IgG levels. (Source: Clinical and Experimental Medicine)
Source: Clinical and Experimental Medicine - April 23, 2024 Category: Research Source Type: research
Current Progress, Challenges and Prospects in the Development of COVID-19 Vaccines
AbstractThe COVID-19 pandemic has resulted in over 772 million confirmed cases, including nearly 7 million deaths, according to the World Health Organization (WHO). Leveraging rapid development, accelerated vaccine approval processes, and large-scale production of various COVID-19 vaccines using different technical platforms, the WHO declared an end to the global health emergency of COVID-19 on May 5, 2023. Current COVID-19 vaccines encompass inactivated, live attenuated, viral vector, protein subunit, nucleic acid (DNA and RNA), and virus-like particle (VLP) vaccines. However, the efficacy of these vaccines is diminishing...
Source: Drugs - April 23, 2024 Category: Drugs & Pharmacology Source Type: research
[[Translated article]]Blistering Disease After COVID-19 Vaccination
Actas Dermosifiliogr. 2024 Apr 20:S0001-7310(24)00345-4. doi: 10.1016/j.ad.2024.04.005. Online ahead of print.NO ABSTRACTPMID:38648927 | DOI:10.1016/j.ad.2024.04.005 (Source: Actas Dermo-Sifiliograficas)
Source: Actas Dermo-Sifiliograficas - April 22, 2024 Category: Dermatology Authors: L Manuela Pulgar ín K Mu ñetón Ramírez R Augusto Rueda Source Type: research
Cerebral Venous Sinus Thrombosis Complicating Herpes Zoster Ophthalmicus Ophthalmoplegia
We report the case of a 68-year-old lady with herpes zoster ophthalmicus ophthalmoplegia who developed cerebral venous thrombosis (CVT).PMID:38646240 | PMC:PMC11026991 | DOI:10.7759/cureus.56520 (Source: Herpes)
Source: Herpes - April 22, 2024 Category: Infectious Diseases Authors: Meithem Ali Nonyelum Obiechina Kay Teck Ling Angela Nandi Bhaskar Mukherjee Source Type: research
Arm lymphedema after vascularized lymph node harvest following Covid-19 vaccination
We report a case of a 40-year-old female who had undergone lymph node transfer for treating primary lymphedema of the legs. Six months later, the patient developed lymphedema of the right arm closely related to mRNA vaccination against COVID-19.PMID:38645421 | PMC:PMC11028028 | DOI:10.1080/23320885.2024.2342332 (Source: Hand Surgery)
Source: Hand Surgery - April 22, 2024 Category: Surgery Authors: Tabea Breckwoldt Pia Niggemann Lisanne Gr ünherz Andrea Weinzierl Nicole Lindenblatt Source Type: research
